Publications by authors named "Barry Buckland"

Claim this Profile
V
Vaccine process technology-A decade of progress.
Barry Buckland, Gautam Sanyal, Todd Ranheim, David Pollard, Jim A Searles

Biotechnol Bioeng· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine.
Janine T Bryan, Barry Buckland, Jennifer Hammond, Kathrin U Jansen

Curr Opin Chem Biol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development and manufacture of influenza vaccines.
Barry C Buckland

Hum Vaccin Immunother· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissolved carbon dioxide determines the productivity of a recombinant hemagglutinin component of an influenza vaccine produced by insect cells.
Jamal Meghrous, Nikolai Khramtsov, Barry C Buckland, Manon M J Cox, Laura A Palomares

Biotechnol Bioeng· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine Technology V: The art of taking vaccines to disease prevention.
Laura A Palomares, Barry C Buckland, Yvonne Genzel, Manon M J Cox

Vaccine· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process.
Barry Buckland, Robert Boulanger, Mireli Fino, Indresh Srivastava, Kathy Holtz

Vaccine· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine Technology IV: an ECI Conference held in Albufeira, Portugal from May 20 to 24, 2012.
David B Weiner, Barry Buckland

Vaccine· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storage.
John M Hickey, Kathleen M Holtz, Prakash Manikwar, Sangeeta B Joshi, Clifton E McPherson, Barry Buckland

J Pharm Sci· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine process technology.
Jessica O Josefsberg, Barry Buckland

Biotechnol Bioeng· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine Technology III: an ECI Conference held in Puerto Vallarta, Mexico from June 6-11, 2010.
Barry C Buckland, John G Aunins, Kathrin Jansen, Paula Marquez Alves, David Weiner

Vaccine· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The process development challenge for a new vaccine.
Barry C Buckland

Nat Med· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward consistent and productive complex media for industrial fermentations: studies on yeast extract for a recombinant yeast fermentation process.
Jinyou Zhang, Jayanthi Reddy, Barry Buckland, Randolph Greasham

Biotechnol Bioeng· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractional precipitation of plasmid DNA from lysate by CTAB.
Russel J Lander, Michael A Winters, Francis J Meacle, Barry C Buckland, Ann L Lee

Biotechnol Bioeng· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis